| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690727 | Gynecologic Oncology | 2016 | 6 Pages |
Abstract
Our study showed that the efficacy of PLD did not differ based on initial dosages, but the risk of adverse events was reduced with PLD40. Considering the balance between patient benefits and risks, our results support the use of PLD40 in clinical practice.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Masahiko Nakayama, Hisanori Kobayashi, Tomihiro Takahara, Yukiko Nishimura, Koji Fukushima, Kazutake Yoshizawa,